E-LIB Suche - Ergebnisse für: Panizo, Carlos

1

Polatuzumab vedotin plus rituximab and lenalidomide in pati..:

Abrisqueta, Pau ; González-Barca, Eva ; Panizo, Carlos...
The Lancet Haematology. 11 (2024) 2 - p. e136-e146 , 2024

2

P-400 An immune atlas of the dysfunctional cellular and ant..:

Martin-Sanchez, Esperanza ; Guerrero, Camila ; Tamariz-Amador, Luis-Esteban...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S261-S262 , 2023

Link: https://doi.org/10.1016/..

3

Preclinical models for prediction of immunotherapy outcomes..:

Larrayoz, Marta ; Garcia-Barchino, Maria J. ; Celay, Jon...
Nature Medicine. 29 (2023) 3 - p. 632-645 , 2023

Link: https://doi.org/10.1038/..

4

Mosunetuzumab monotherapy is active and tolerable in patien..:

Bartlett, Nancy L. ; Assouline, Sarit ; Giri, Pratyush...
Blood Advances. 7 (2023) 17 - p. 4926-4935 , 2023

Link: https://doi.org/10.1182/..

5

P1552: AN IMMUNE ATLAS OF THE DYSFUNCTIONAL CELLULAR AND AN..:

Martín-Sánchez, Esperanza ; Guerrero, Camila ; Tamariz-Amador, Luis-Esteban...
HemaSphere. 7 (2023) S3 - p. e4536414 , 2023

Link: https://doi.org/10.1097/..

6

Low‐risk HPLLs/ABC score patients with splenic marginal zon..:

Muntañola, Ana ; Villalobos, María Teresa ; González‐Villambrosia, Sonia...
British Journal of Haematology. 202 (2023) 4 - p. 776-784 , 2023

Link: https://doi.org/10.1111/..

7

Venetoclax improves CD20 immunotherapy in a mouse model of ..:

Melchor, Javier ; Garcia-Lacarte, Marcos ; Grijalba, Sara C....
Journal for ImmunoTherapy of Cancer. 11 (2023) 2 - p. e006113 , 2023

Link: https://doi.org/10.1136/..

8

Immune biomarkers to predict SARS-CoV-2 vaccine effectivene..:

Tamariz-Amador, Luis-Esteban ; Battaglia, Anna Martina ; Maia, Catarina...
Blood Cancer Journal. 11 (2021) 12 - p. , 2021

Link: https://doi.org/10.1038/..

9

Ibrutinib does not have clinically relevant interactions wi..:

Jong, Jan ; Mitselos, Anna ; Jurczak, Wojciech...
Pharmacology Research & Perspectives. 8 (2020) 5 - p. , 2020

Link: https://doi.org/10.1002/..

10

Maintenance therapy with ex vivo expanded lymphokine‐activa..:

López‐Díaz de Cerio, Ascensión ; García‐Muñoz, Ricardo ; Pena, Esther...
British Journal of Haematology. 189 (2020) 6 - p. 1064-1073 , 2020

Link: https://doi.org/10.1111/..

11

Long-term follow-up of a prospective phase 2 clinical trial..:

on behalf of the GELTAMO (Spanish Lymphoma Group) and GOTEL (Group of Oncology for Therapy and Study of Lymphomas) ; González-Barca, Eva ; Capote, Francisco Javier...
Annals of Hematology. 100 (2020) 4 - p. 1023-1029 , 2020

Link: https://doi.org/10.1007/..

12

RELINF: prospective epidemiological registry of lymphoid ne..:

Bastos-Oreiro, Mariana ; Muntañola, Ana ; Panizo, Carlos...
Annals of Hematology. 99 (2020) 4 - p. 799-808 , 2020

Link: https://doi.org/10.1007/..

13

Long-Term Follow-Up of Acalabrutinib Monotherapy in Patient..:

Wang, Michael ; Rule, Simon ; Zinzani, Pier Luigi...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) - p. S316 , 2019

Link: https://doi.org/10.1016/..

14

Durable response with single-agent acalabrutinib in patient..:

Wang, Michael ; Rule, Simon ; Zinzani, Pier Luigi...
Leukemia. 33 (2019) 11 - p. 2762-2766 , 2019

Link: https://doi.org/10.1038/..

15

Battle of Thermopylae: 300 Spartans (natural Killer Cells P..:

García-Muñoz, Ricardo ; Nájera, María-Josefa ; Feliu, Jesús...
Future Science OA. 5 (2019) 10 - p. , 2019

Link: https://doi.org/10.2144/..